Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Pathophysiology of Vomiting
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 22, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Kerstin Kolodzie1, Christian C Apfel
1Perioperative Clinical Research Core, Department of Anesthesia & Perioperative Care, University of California San Francisco, San Francisco, California 94115, USA.
Postdischarge nausea and vomiting (PDNV) is an under-recognized issue impacting patient recovery and outpatient surgery costs. Identifying at-risk patients with a prediction model is crucial for effective antiemetic prophylaxis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: